Protein Kinase Cε Is a Predictive Biomarker of Aggressive Breast Cancer and a Validated Target for RNA Interference Anticancer Therapy
Authors:
Open Access
- 15 September 2005
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 65 (18) , 8366-8371
Abstract
Tumor metastasis is the major cause of morbidity and mortality in patients with breast cancer. It is critical to identify metastasis enabling genes and understand how they are responsible for inducing specific aspects of the metastatic phenotype to allow for improved clinical detection and management. Protein kinase Cε (PKCε), a member of a family of serine/threonine protein kinases, is a transforming oncogene that has been reported to be involved in cell invasion and motility. In this study, we investigated the role of PKCε in breast cancer development and progression. High-density tissue microarray analysis showed that PKCε protein was detected in 73.6% (106 of 144) of primary tumors from invasive ductal breast cancer patients. Increasing PKCε staining intensity was associated with high histologic grade (P = 0.0206), positive Her2/neu receptor status (P = 0.0419), and negative estrogen (P = 0.0026) and progesterone receptor status (P = 0.0008). Kaplan-Meier analyses showed that PKCε was significantly associated with poorer disease-free and overall survival (log-rank, P = 0.0478 and P = 0.0414, respectively). RNA interference of PKCε in MDA-MB231 cells, an aggressive breast cancer cell line with elevated PKCε levels, resulted in a cell phenotype that was significantly less proliferative, invasive, and motile than the parental or the control RNA interference transfectants. Moreover, in vivo tumor growth of small interfering RNA-PKCε MDA-MB231 clones was retarded by a striking 87% (P < 0.05) and incidence of lung metastases was inhibited by 83% (P < 0.02). PKCε-deficient clones were found to have lower RhoC GTPase protein levels and activation. Taken together, these results revealed that PKCε plays a critical and causative role in promoting an aggressive metastatic breast cancer phenotype and as a target for anticancer therapy.Keywords
This publication has 26 references indexed in Scilit:
- Protein Kinase Cα-Induced p115RhoGEF Phosphorylation Signals Endothelial Cytoskeletal RearrangementJournal of Biological Chemistry, 2003
- The Anchoring Protein RACK1 Links Protein Kinase Cε to Integrin β ChainsJournal of Biological Chemistry, 2002
- AKT/PKB Phosphorylation of p21Cip/WAF1 Enhances Protein Stability of p21Cip/WAF1 and Promotes Cell SurvivalJournal of Biological Chemistry, 2002
- Characterization of RhoC Expression in Benign and Malignant Breast DiseaseThe American Journal of Pathology, 2002
- RHO–GTPases and cancerNature Reviews Cancer, 2002
- PKCδ acts as a growth and tumor suppressor in rat colonic epithelial cellsOncogene, 1999
- Regulation of protein kinase CCurrent Opinion in Cell Biology, 1997
- Protein kinase C isozymes and substratesCurrent Opinion in Cell Biology, 1996
- Guanine nucleotide exchange factors: Activators of Ras superfamily proteinsMolecular Reproduction and Development, 1995
- A novel ras-related gene familyCell, 1985